Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
DIA 2021 Global Annual Meeting
The Journey to a Modernization of Analytics
Session Chair(s)
Peter Mesenbrink, PhD
- Executive Director of Biostatistics
- Novartis Pharmaceuticals Corporation, United States
This forum will present on the statistical analytics assessment framework based on risk as to the factors that contribute to confidence or trust for various statistical software, tools, and applications. A panel of experts will provide their experiences.
Learning Objective : Describe best practices to achieve a modernization of analytics within biostatistics and data science.
Speaker(s)
Changing How We Use Modern Analytics in Clinical Drug Development
Peter Mesenbrink, PhD
- Executive Director of Biostatistics
- Novartis Pharmaceuticals Corporation, United States

Industry Update
Daniel Woodie, MS
- Senior Scientist, Statistical Programming
- Merck & Co., Inc., United States

Industry Update
Andy Nicholls, MSc
- Senior Director, Head of Statistical Data Sciences
- GlaxoSmithKline, United Kingdom

Industry Update
Min Lee
- Director of Biostatistical Programming
- Amgen, United States